1Wilson SE,Perry HD.Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment[J].Ophthalmology,2007,114(1):76-79.
3Kunert Arch Kunert KS,Tisdale AS,Stern ME,et al.Analysis of topical cyclosporine treatment of patients with dry eye syndrome:effect on conjunctival lymphocytes[J].Arch Ophthalmol,2000,118(11):1489-1592.
4Christensen MT,Cohen S,Rinehart J,et al.Clinical evaluation of an HP guargellable lubricant eye drop for the relief of dryness of the eye[J].Curr Eye Res,2004,28(1):55-62.
5Lee S,Dausch S,Maierhofer G,et al.A new therapy concept for the treatment of dry eye-the usefulness of phospholipidliposomes[J].Klin Monatsbl Augenheilkd,2004,221(10):825-836.
6Stephen CP.Anti-inflammatory therapy for dry eye[J].Am J Ophthalmol,2004,137(2):337.
7Avni MA,Mustafa CA,Emily DV,et al.The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients:A clinical and immunocytochemical study[J].Am J Ophthalmol,2003,136(4):593.
8Stevenson D,Tauber J,Reis BL.Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate to severe dry eye disease:a dose ranging,randomized trial.The cyclosporinaphase 2 study group[J].Ophthalmology,2000,107(5):967-974.
9Aoki S,Mizote H,Minamoto A,et al.Systemic FK506 improved tears ecretionin dry eye associated with chronic graft versus host disease[J].Br J Ophthalmol,2005,89(2):243-244.